HIV
Conference Coverage
Weight gain persists as HIV-treatment issue
Conference Coverage
Easy access to PrEP reduces rates of HIV acquisition
“We haven’t really seen PrEP being scaled up and offered at such a broad level in communities,” Koss said during AIDS 2020.
From the Journals
HSCT or systemic treatment should be offered to HIV+ patients with lymphoma
Conference Coverage
Injection beats pill for long-lasting HIV prevention
The findings “could transform the HIV prevention landscape for so many people,” said Megan Coleman, DNP.
Conference Coverage
Neural tube defect risk from dolutegravir drops as clinical experience grows
A troubling link between the top HIV drug dolutegravir and neural tube defects, first reported in 2018, now seems much less dangerous.
Conference Coverage
Brazilian patient in HIV remission, negative antibody test
The 35-year-old Brazilian man participated in a trial in which he received an intensified antiretroviral regimen plus supplemental vitamin B3...
News from the FDA/CDC
FDA OKs first-in-class HIV therapy for patients with few options
“The availability of new classes of antiretroviral drugs is critical for heavily treatment-experienced patients living with multidrug resistant...
Conference Coverage
Holistic HIV care broadens scope to noncommunicable diseases
Conference Coverage
COVID-19 disruptions ‘life threatening’ for people with HIV
Conference Coverage
HIV does not appear to worsen COVID-19 outcomes
“We don’t see any signs that people with HIV should take extra precautions” to protect themselves from COVID-19, said Keith Sigel, MD.
Commentary
‘COVID-sorting’: How we decide whom to get close to and whom to avoid
Patients are making calculations about managing physical distancing using their own internal formulas, said Dr. Jack Drescher.